JP2006502249A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502249A5
JP2006502249A5 JP2004523573A JP2004523573A JP2006502249A5 JP 2006502249 A5 JP2006502249 A5 JP 2006502249A5 JP 2004523573 A JP2004523573 A JP 2004523573A JP 2004523573 A JP2004523573 A JP 2004523573A JP 2006502249 A5 JP2006502249 A5 JP 2006502249A5
Authority
JP
Japan
Prior art keywords
sodium
potassium
polystyrene sulfonate
ions
sulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004523573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502249A (ja
JP4476807B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/022514 external-priority patent/WO2004009100A1/en
Publication of JP2006502249A publication Critical patent/JP2006502249A/ja
Publication of JP2006502249A5 publication Critical patent/JP2006502249A5/ja
Application granted granted Critical
Publication of JP4476807B2 publication Critical patent/JP4476807B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004523573A 2002-07-22 2003-07-18 ポリ（カリウムおよびスチレンスルホン酸ナトリウム）、その製造およびその使用 Expired - Lifetime JP4476807B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39786802P 2002-07-22 2002-07-22
PCT/US2003/022514 WO2004009100A1 (en) 2002-07-22 2003-07-18 Poly (potassium and sodium styrene sulfonate), its manufacture and its uses

Publications (3)

Publication Number Publication Date
JP2006502249A JP2006502249A (ja) 2006-01-19
JP2006502249A5 true JP2006502249A5 (https=) 2006-07-13
JP4476807B2 JP4476807B2 (ja) 2010-06-09

Family

ID=30771134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004523573A Expired - Lifetime JP4476807B2 (ja) 2002-07-22 2003-07-18 ポリ（カリウムおよびスチレンスルホン酸ナトリウム）、その製造およびその使用

Country Status (11)

Country Link
US (4) US20050214246A1 (https=)
EP (1) EP1542706A1 (https=)
JP (1) JP4476807B2 (https=)
KR (1) KR20050030208A (https=)
CN (3) CN101081230A (https=)
AU (1) AU2003254007B2 (https=)
BR (1) BR0312884A (https=)
CA (1) CA2492211A1 (https=)
MX (1) MXPA05000687A (https=)
NZ (1) NZ537594A (https=)
WO (1) WO2004009100A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951853B2 (en) * 2002-05-02 2011-05-31 Smart Anti-Microbial Solutions, Llc Polymer-based antimicrobial agents, methods of making said agents, and products incorporating said agents
EP1542706A1 (en) * 2002-07-22 2005-06-22 Genzyme Corporation Poly (potassium and sodium styrene sulfonate), its manufacture and its uses
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
US20060078534A1 (en) * 2004-10-13 2006-04-13 Dominique Charmot Toxin binding compositions
US20060099169A1 (en) * 2004-10-13 2006-05-11 Ilypsa, Inc. Toxin binding compositions
US20120135060A1 (en) * 2005-11-02 2012-05-31 Shmuel Bukshpan Compositions and methods for cell killing
EP1948201A4 (en) 2005-11-14 2013-12-25 Valorisation Recherche Ltd Partnership PHARMACEUTICAL COMPOSITIONS WITH POLYMER BINDERS WITH NON-HYDROLYZABLE COVALENT BINDINGS AND THEIR USE IN THE TREATMENT OF CELIAC DISEASE
US7915235B2 (en) * 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
TW200829286A (en) * 2006-09-06 2008-07-16 Genzyme Corp Polystyrene sulfonate polymer tablets, their preparation and use
JP5954798B2 (ja) * 2011-11-16 2016-07-20 東ソー有機化学株式会社 高純度パラスチレンスルホン酸（塩）、それを用いたポリスチレンスルホン酸（塩）、およびポリスチレンスルホン酸（塩）を用いた、分散剤、導電性ポリマードーパント、ナノカーボン材料水性分散体、導電性ポリマー水性分散体、ならびにポリスチレンスルホン酸（塩）の製造方法
KR102545700B1 (ko) * 2020-12-08 2023-06-21 동아대학교 산학협력단 폴리스티렌설폰산 금속염, 이의 제조방법 및 이를 포함하는 조성물

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3224941A (en) * 1963-01-21 1965-12-21 Lilly Co Eli Resin compositions and method for controlling diarrhea
DE1480628C3 (de) * 1965-10-28 1975-02-06 Alfred 2000 Hamburg Wriedt Kupplung für einen Förderkarrenzug
US3466365A (en) * 1967-07-24 1969-09-09 White Lab Inc Antiviral compositions and method of use
US3987163A (en) * 1973-07-27 1976-10-19 Burton, Parsons And Company, Inc. Polystyrene sulfonate containing opthalmic solutions
IE44690B1 (en) * 1976-02-04 1982-02-24 Rohm & Haas Pharmaceutical compositions containing polyvinylbenzenosulfonic acids
US4395392A (en) * 1980-06-24 1983-07-26 Adria Laboratories Inc. Method for treating kidney stones
US4362711A (en) * 1980-07-11 1982-12-07 Evreka Inc. Blood cholesterol level reducing agent and method
US5171738A (en) * 1982-10-04 1992-12-15 Toray Industries, Inc. Method of treating malignant tumors
US5435821A (en) * 1985-12-12 1995-07-25 Exxon Research & Engineering Co. Controlled release vegetation enhancement agents coated with sulfonated polymers, method of production and prcesses of use
US5071759A (en) * 1986-05-30 1991-12-10 The United States Of America As Represented By The Secretary Of The Army Hybridoma cell lines and monoclonal antibodies to clostridum difficile toxins A and B
US4837015A (en) * 1987-03-05 1989-06-06 Carolina Medical Products Company, Inc. Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels
IL90388A (en) * 1988-05-26 1993-08-18 Duphar Int Res Pharmaceutical compositions having anti- endotoxic activity containing a novel active fraction from lactulose syrup, and a method for its preparation
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
US5093130A (en) * 1989-09-26 1992-03-03 Plant Genetics Powder coated hydrogel capsules
US5736139A (en) * 1989-10-31 1998-04-07 Ochidian Pharmaceuticals, Inc. Treatment of Clostridium difficile induced disease
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5231003A (en) * 1990-05-11 1993-07-27 Cambridge Bioscience Corporation Monoclonal antibodies specific for toxin b of clostridium difficile
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5277820A (en) * 1992-02-06 1994-01-11 Hemocleanse, Inc. Device and method for extracorporeal blood treatment
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
US5614559A (en) * 1993-11-23 1997-03-25 Procept Inc. Compound for inhibiting HIV infectivity
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea
US5756810A (en) * 1994-03-11 1998-05-26 Pharmacopeia, Inc. Process of preparing 3-nitro benzoate compounds in lower alkanol
EP0779819A1 (en) * 1994-09-06 1997-06-25 Galagen Inc. Therapeutic treatment of clostridium difficile associated diseases
EP0704697A1 (en) * 1994-09-27 1996-04-03 General Motors Corporation Exhaust sensor including a ceramic tube in metal tube package
US5610023A (en) * 1995-03-31 1997-03-11 Lee Laboratories, Inc. Method of purification of clostridium difficile toxin A and production of mono-specific antibodies
DE19515554C2 (de) * 1995-04-27 1999-06-17 Braun Melsungen Ag Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US6034129A (en) * 1996-06-24 2000-03-07 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
US5800803A (en) * 1997-02-10 1998-09-01 Colgate-Palmolive Company Oral composition exhibiting enhanced uptake by dental tissue of noncationic antibacterial agents
WO1998058654A1 (fr) * 1997-06-20 1998-12-30 Ohkura Pharmaceutical Co., Ltd. Composition sous forme de gel
US6060235A (en) * 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US6290947B1 (en) * 1997-09-19 2001-09-18 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin-binding agents
US6007803A (en) * 1997-09-19 1999-12-28 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin binding agents
WO1999020285A1 (en) * 1997-10-16 1999-04-29 Sanwa Kagaku Kenkyusho Co., Ltd. Gel preparations containing polystyrenesulfonate
US6221248B1 (en) * 1998-03-23 2001-04-24 Ionics Incorporated Styrene sulfonate cation exchange membrane
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
US6270755B1 (en) * 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
US6290946B1 (en) * 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
CA2314494A1 (en) * 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
US6537538B2 (en) * 2000-12-18 2003-03-25 Rush-Presbyterian-St. Luke's Medical Center Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate
EP1542706A1 (en) * 2002-07-22 2005-06-22 Genzyme Corporation Poly (potassium and sodium styrene sulfonate), its manufacture and its uses
KR100714648B1 (ko) * 2005-12-02 2007-05-07 삼성전자주식회사 인쇄 회로 기판

Similar Documents

Publication Publication Date Title
JP2006502249A5 (https=)
HRP20110181T1 (hr) Novi postupak u jednom koraku za pripremu umreženih polimera poli(alilamina)
JP2010533758A5 (https=)
CN103201298B (zh) 生产磺化的嵌段共聚物组合物的方法
CN105143293A (zh) 具有两亲性嵌段的共聚物及其用于制造聚合物滤膜的用途
RU2018142943A (ru) Композиции для лечения нарушений кислотно-основного равновесия
US20090175818A1 (en) Poly(Potassium and Sodium Styrene Sulfonate) Its Manufacture and Its Uses
JPH09501722A (ja) 強塩基性アニオン交換膜及びその製造方法
EP2188052B1 (en) Process for separating charged species from an aqueous system
CN105879702A (zh) 一种壳聚糖磷酸酯复合纳滤膜的制备方法
SE426835B (sv) Terapeutisk produkt bestaende av en polymer med vinylbensensulfonatenheter
CN101723978B (zh) 磺化膦氧化物单体及其盐的高效制备方法
JP2015528509A5 (https=)
US3579613A (en) Polysalts containing sulfonated acrylics
CN107556430A (zh) 一种可溶性两性离子水凝胶及其制备方法
TW201237073A (en) A cross-linking method and articles produced thereby
CN121177987B (zh) 一种应用于血液净化的阴离子交换树脂膜及其制备方法
Samsonov Ion-exchange equilibrium, thermodynamics, and sorption selectivity of organic and physiologically active substances
CN113731196B (zh) 一种用于去除水中氟化物的混合基质膜及其制备方法
JP4300479B2 (ja) 遊離のアリルアミン類重合体水溶液の製造方法および遊離のジアリルアミン類重合体水溶液
US7214316B2 (en) Apparatus containing phosphate selective resin
Bdair et al. Transport of sodium chloride, urea, and creatinine through membranes derived from methylmethacrylate‐co‐methacrylic acid and its ionomers
JP2010229196A (ja) ジアリル化合物とマレイン酸との共重合体の製造方法
JPH0556363B2 (https=)
JPS58500396A (ja) イオン交換樹脂